Scientific Advisory Board communications

Jean-Marc Sabatier has a Ph.D. and HDR in biochemistry. He is the director of research at the French Centre National de la Recherche Scientifique (CNRS). He heads a research laboratory (ERT 62) entided Engineering of Therapeutic Peptides at the Universite de la Mediterranee, in Marseilles, France. He also holds the position of a senior director (discovery research — peptides) for a public company in Canada. Dr. Sabatier works in the field of animal toxins, and leads the venom peptide group of the International Neuropeptide Society. He also designs immunomodulatory and antiviral drugs, as well as contributes to the field of peptide and protein engineering. He has contributed more than 100 scientific articles, 180 communications, and 43 patents. He is a member of several scientific advisory boards of journals (e.g.. Peptides, Biochemical Journal), and has reviewed articles submitted for publication in more than 30 specialized international journals. 

Just as this book was nearing completion, our colleague Don Wiley tragically disappeared while attending a scientific advisory board meeting of St. Jude s Children s Research Hospital in Memphis, Tennessee. At that time, we had not yet mutually agreed upon a title. Don s latest communication to us on this topic was I like the title that ends Ashes to Enzymes. It is so biblical. Consequently, we decided to use that title. 

The Director-General may dismiss any member of the Scientific Advisory Board for just cause, such as a breach of confidentiality, or a gross breach of the code of conduct detailed in Rule 8 above. In case of dismissal, the Director-General shall communicate in writing the reasons for the dismissal to the Board members, including the Board member concerned. Thereafter, the Director-General will report any such dismissal to the Conference of the States Parties, as appropriate. 

Burwell s contributions to the scientific community include service on the governing body of the North American Catalysis Society from 1964 to 1977 as Director, Vice President, and, from 1973 until 1977, President. From 1955 until 1984 he served the International Congress on Catalysis, as a member of the Board of Directors as U.S Representative Vice President and President (1980-84). He chaired the Gordon Research Conference on Catalysis in 1957 and was Associate Editor (1984-88) and a member of the Editorial Board of Journal of Catalysis. He served on National Research Council committees, IUPAC committees, the Petroleum Research Fund Advisory Board, the National Science Foundation... 

Suggestions for new topics from the scientific community to members of the Advisory Board or to the Publisher are very welcome. 

A number of experts in the scientific and libary communities provided invaluable assistance in the formulation of this encyclopedia. Our advisory board performed a m5Tiad of duties, from defining the scope of coverage to reviewing individual entries for accuracy and accessibility, and in many cases, writing entries. We would therefore like to express our appreciation to them ... 

One of the CERCLA and RCRA remedy selection factors noted earlier is community acceptance. It is, however, only a modifying factor. Community members can influence and sometimes take actions that lead to the rejection of remedial alternatives that they oppose, but they do not have the authority to veto otherwise scientifically acceptable alternatives.10 There are also additional, more formal activities associated with federal facility restoration activities, such as funding of restoration site advisory boards composed of local citizens. 

---